Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes

Ayaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So · 2025

Read Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes by Ayaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11757143.txt.

Description

Ayaka Sato and co-authors engineered a soluble protein that switches on a T cell growth signal, in a study published in 2024. The signal comes from OX40, a receptor that appears on active T cells and boosts their growth and survival. Its natural partner sits fixed on cell surfaces, which makes it hard to copy as a drug. The team built stand-in proteins with parts that cluster the partner into effective groups.

Their proteins bound the receptor, fired its internal pathway, and made T cells release signaling molecules in dishes. In mice, one design strongly expanded the T cells matched to a test antigen. Sister designs carrying partners for three other receptors worked in the same way. The authors say tuned clustering may yield stronger immune therapy agents.

Catalog record

CREATORAyaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11757143

Browse the full library · About the Tower of Babel